MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0039790
Universal Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.2 Cr
▲ 189% YoY
Net profit · FY 2025
₹2.82 Cr
Net margin 9.7%
EBITDA · FY 2025
₹3.26 Cr
EBITDA margin 11.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹5.1 Lakh
Issued & subscribed
Open charges
₹9.8 Cr
Satisfied ₹4.08 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
50
Provident fund records
About Universal Pharmaceuticals Private Limited
Data last updated:
Universal Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1990PTC019449. Its GSTIN is 33AAACU3759R1ZQ (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹5.1 Lakh. It was formerly known as Universal Pharmaceuticals Ltd. It is led by directors Shew Ratan Marda and Kalimuthu Babu.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No1 Grihalakshmi Shopping Complex Vaidyanathan Street Tondiarpet, Chennai, Tamil Nadu, India – 600081.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.2 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.82 Cr (net margin 9.7%) and EBITDA of ₹3.26 Cr (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 30% over five years.
The company has about 50 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.8 Cr and satisfied charges of ₹4.08 Cr on record. Court records list 5 cases involving the company, including 5 filed by the company; 4 cases are pending.
Universal Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0039790). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unipha.co.in.
Company details
CIN U24231TN1990PTC019449
Registration Number 019449
Incorporation Date 27 July 1990
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0039790
CIN history
Universal Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231TN1990PLC019449. The current CIN is U24231TN1990PTC019449, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TN1990PTC019449 | Current |
| U24231TN1990PLC019449 | Previous |
Key People
Shew Ratan Marda Director Kalimuthu Babu Director Recognitions & Rankings of Universal Pharmaceuticals
Contact details
Universal Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is unipha.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo1 Grihalakshmi Shopping Complex Vaidyanathan Street Tondiarpet, Chennai, Tamil Nadu, India – 600081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Universal Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Universal Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Universal Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Universal Pharmaceuticals Private Limited, buy the company report.
Financials of Universal Pharmaceuticals Private Limited
FY 2024 filings availableUniversal Pharmaceuticals Private Limited reported revenue of ₹29.2 Cr (up 189% YoY) for FY 2025.
Revenue · FY 2025
₹29.2 Cr ▲ 189%
Net profit · FY 2025
₹2.82 Cr margin 9.7%
EBITDA · FY 2025
₹3.26 Cr margin 11.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 189%
3 years · compounded
▲ 35%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 105%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 189% growth in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 9.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Universal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Universal Pharmaceuticals Private Limited
Universal Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shew Ratan Marda | Director | 10 Aug 2006 | 20 Years 2 Months | Current |
| Kalimuthu Babu | Director | 02 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Universal Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rapross Pharmaceuticals Private Limited | ₹29.39 Cr (FY 2023) | 3.0% | Delhi, India | |||
| Puerto Life Sciences Private Limited | ₹29.22 Cr (FY 2025) | -10.0% | Delhi, India | |||
| Saf Fermion Ltd. | ₹29.2 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Universal Pharmaceuticals Private Limitedthis company | ₹29.2 Cr (FY 2025) | ₹2.82 Cr | 9.7% | 189.0% | 50 | Chennai, Tamil Nadu, India |
| Ocean Pharmacoat Private Limited | ₹29.07 Cr (FY 2024) | -37.0% | Telangana, India | |||
| Sparsha Pharma International Private Limited | ₹29.04 Cr (FY 2025) | -4.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Universal Pharmaceuticals Private Limited, buy the company report.
Auditor
Universal Pharmaceuticals Private Limited is audited by M C RANGANATHAN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M C RANGANATHAN & CO | FY 2023 | 003061S |
Shareholding
The shareholding of Universal Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Universal Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.8 Cr
Satisfied charges
₹4.08 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2017 | 100193669 | Canara Bank | ₹5.5 Lakh | Open | |
| 21 Sep 2006 | 10022867 | Canara Bank | ₹4.29 Cr | Open | |
| 14 Aug 2004 | 90302311 | Indian Bank | ₹2.73 Cr | Open | |
| 14 Aug 2004 | 90301267 | Indian Bank | ₹2.73 Cr | Open | |
| 02 Jun 2005 | 80059336 | Icici Bank Limted | ₹2.04 Cr | Satisfied |
To see the full charge records of Universal Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Universal Pharmaceuticals Private Limited has 5 court cases on record: 5 filed by Universal Pharmaceuticals. 4 cases are pending and 1 is disposed.
Total cases
5
Filed by the company
5
Pending
4
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 4 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Interim or miscellaneous application | Filed by the company against The Union of India, | Pending |
| High Court, TAMIL NADU | Writ petition | Filed by the company against The Union of India and 1 other | Pending |
| High Court, TAMIL NADU | Writ petition | Filed by the company against The Union of India, and 1 other | Pending |
| Bombay High Court | Court case (APPLN) | Filed by the company against The State of Maharashtra and Anr | Disposed |
To see the full case history of Universal Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Universal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Universal Pharmaceuticals has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Universal Pharmaceuticals Private Limited has a workforce of 50 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
50
Active EPFO establishments
1
Employee growth
-1.96%
GST
Universal Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACU3759R1ZQ | Tamil Nadu | Active | 01 Jul 2017 |
| 34AAACU3759R1ZO | Puducherry | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Universal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Universal Pharmaceuticals Private Limited has 5 board changes on record since 2006: 2 appointments and 3 cessations. The latest: Kalimuthu Babu ceased to be Additional Director on 29 Sep 2024.
AGM
Universal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Kalimuthu Babu ceased to be Additional Director.
Filing
Universal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Sivakumar Swaminathan ceased to be Director.
Appointed
Kalimuthu Babu was appointed as Director.
Ceased
Parambath Sreenivasan Padmanabhan Nair ceased to be Director.
Charges
A charge with Canara Bank of Rs. 4.29 Cr registered on 21 Sep 2006 with Charge ID 10022867 was modified on 15 Jun 2020.
Charges
A charge with Canara Bank amounted to Rs. 0.06 Cr with Charge ID 100193669 was registered on 30 Dec 2017.
Charges
A charge registered on 02 Jun 2005 via Charge ID 80059336 with Icici Bank Limted was fully satisfied on 11 Jun 2010.
Charges
A charge registered on 02 Jun 2005 via Charge ID 90301353 with Icici Bank Ltd. was fully satisfied on 01 Mar 2007.
Charges
A charge with Canara Bank amounted to Rs. 4.29 Cr with Charge ID 10022867 was registered on 21 Sep 2006.
Appointed
Shew Ratan Marda was appointed as Director.
7 earlier events are in the company report.
Frequently asked questions
Universal Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 1990 (36+ years old) and is registered under CIN U24231TN1990PTC019449.
Universal Pharmaceuticals has 2 current directors:
- Shew Ratan Marda - Director
- Kalimuthu Babu - Director
The latest financial statements of Universal Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Universal Pharmaceuticals is 33AAACU3759R1ZQ, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 34AAACU3759R1ZO (Puducherry).
The CIN (Corporate Identification Number) of Universal Pharmaceuticals is U24231TN1990PTC019449. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Universal Pharmaceuticals has 5 court cases on record: 5 filed by the company. 4 are pending.
Universal Pharmaceuticals was incorporated on 27 July 1990, making it 36+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Universal Pharmaceuticals by revenue are Rapross Pharmaceuticals Private Limited, Puerto Life Sciences Private Limited, Saf Fermion Ltd, Ocean Pharmacoat Private Limited, Sparsha Pharma International Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kalimuthu Babu ceased to be Additional Director on 29 Sep 2024. Sivakumar Swaminathan ceased to be Director on 23 Nov 2023. Kalimuthu Babu was appointed as Director on 02 Nov 2023. Universal Pharmaceuticals has 5 board changes on record in total.
Yes, Universal Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0039790).
Universal Pharmaceuticals can be reached through the website unipha.co.in. Its registered office is in Chennai, Tamil Nadu, India.